RESUMO
OBJECTIVE: To describe timely vaccination completion and obstacles in the first 24 months of life in Brazil, examining associations with maternal race/skin color. METHODS: Study participants were 37,801 children born in 2017 and 2018 included in the National Immunization Coverage Survey. We calculated prevalence and 95% confidence intervals for timely vaccine completeness and obstacles at 5, 12 and 24 months of life, according to maternal race/skin color. Associations were analyzed using logistic regression. RESULTS: 7.2% (95%CI 6.3;8.2) of mothers faced difficulties in taking their children to be vaccinated, and 23.4% (95%CI 21.7;25.1) were not vaccinated when taken. These proportions were 75% (95%CI 1.25;2.45) and 97% (95%CI 1.57;2.48) higher, respectively, among Black mothers. At least one vaccination was delayed among 49.9% (95%CI 47.8;51.9) and 61.1% (95%CI 59.2;63.0) of children by 5 and 12 months, respectively. These rates were higher among Black/mixed race mothers. CONCLUSION: There are racial inequalities in both the obstacles faced and in vaccination rates in Brazil. MAIN RESULTS: Marked racial inequalities were found in the obstacles to vaccination of children under 24 months in Brazil and to timely vaccination at 5 months and in the first year of life. IMPLICATIONS FOR SERVICES: Racial inequalities in the occurrence of vaccination shortcomings in health services, in the objective restrictions faced by families in taking their children to vaccination centers and in incomplete vaccination in a timely manner need to be addressed by the Brazilian National Health System. PERSPECTIVES: Equal public policies to address barriers to vaccination and qualification of health services need to be implemented. Studies need to deepen understanding of the structural determinants that lead to racial disparities.
Assuntos
Disparidades em Assistência à Saúde , Mães , Vacinação , Humanos , Brasil , Lactente , Vacinação/estatística & dados numéricos , Feminino , Estudos Retrospectivos , Disparidades em Assistência à Saúde/estatística & dados numéricos , Mães/estatística & dados numéricos , Pré-Escolar , Masculino , Cobertura Vacinal/estatística & dados numéricos , Recém-Nascido , Adulto , Estudos de Coortes , Fatores Socioeconômicos , População Negra/estatística & dados numéricos , Fatores de Tempo , Programas de Imunização/estatística & dados numéricos , Acessibilidade aos Serviços de Saúde/estatística & dados numéricos , Adulto Jovem , População Branca/estatística & dados numéricosRESUMO
This article seeks to identify and discuss evidence-informed options to address the judicialization of health. The Supporting Policy Relevant Reviews and Trials Tools were used to define the problem and the search strategy, which was carried out in the following databases: PubMed, Health Systems Evidence, Campbell, Cochrane Collaboration, Rx for Change Database, and PDQ-Evidence. Selection and assessment of methodological quality was performed by two independent reviewers. The results were presented in a narrative synthesis. This study selected 19 systematic reviews that pointed out four strategies to address the judicialization of health in Brazil: 1) Rapid response service, 2) Continuous education program, 3) Mediation service between the parties involved, and 4) Adoption of a computer-based, online decision-making support tool and patient-mediated interventions. This study therefore presented and characterized four options that can be considered to address the judicialization of health. The implementation of these options must ensure the participation of different actors, reflecting on different contexts and the impact on the health system. The availability of human and financial resources and the training of teams are critical points for the successful implementation of the options.
A fim de identificar e discutir opções informadas por evidências para abordar a judicialização da saúde no Brasil, utilizou-se as Ferramentas SUPPORT (Supporting Policy Relevant Reviews and Trials). A busca foi realizada nas bases PubMed; Health Systems Evidence; Campbell Collaboration; Cochrane Library; Rx for Change Database e PDQ-Evidence. A seleção e avaliação da qualidade metodológica foi feita por dois revisores independentes. Os resultados foram apresentados numa síntese narrativa. Dezenove revisões sistemáticas apontam quatro opções: 1) Serviço de respostas rápidas; 2) Programa de educação permanente; 3) Serviço de mediação entre as partes envolvidas; e 4) Adoção de ferramenta online (baseada em computador) de suporte à decisão e de intervenções mediadas por pacientes. Conclusões: Apresentamos e caracterizamos quatro opções que podem ser consideradas para abordar a judicialização da saúde. A implementação dessas opções deve garantir a participação de diferentes atores, refletindo sobre variados contextos. Recursos humanos e financeiros, capacitação das equipes, são os principais pontos críticos.
Assuntos
Política de Saúde , Saúde Pública , Humanos , Brasil , Saúde Pública/legislação & jurisprudência , Negociação , Tomada de Decisões , Sistemas de Apoio a Decisões ClínicasRESUMO
OBJECTIVE: To evaluate the implications of the proportion of annual family income spent in the pre- and post-diagnosis periods in tuberculosis patients followed for after at least one year after completing tuberculosis treatment in Brazil. METHODS: This was a cross-sectional study of tuberculosis patients followed for at least one year after completing tuberculosis treatment in five Brazilian capitals (one in each region of the country). RESULTS: A total of 62 patients were included in the analysis. The overall average cost of tuberculosis was 283.84 Brazilian reals (R$) in the pre-diagnosis period and R$4,161.86 in the post-diagnosis period. After the costs of tuberculosis disease, 71% of the patients became unemployed, with an overall increase in unemployment; in addition, the number of patients living in nonpoverty decreased by 5%, the number of patients living in poverty increased by 6%, and the number of patients living in extreme poverty increased by 5%. The largest proportion of annual household income to cover the total costs of tuberculosis was for the extremely poor (i.e., 40.37% vs. 11.43% for the less poor). CONCLUSIONS: Policies to mitigate catastrophic costs should include interventions planned by the health care system and social protection measures for tuberculosis patients with lower incomes in order to eliminate the global tuberculosis epidemic by 2035-a WHO goal in line with the United Nations Sustainable Development Goals.
Assuntos
Estresse Financeiro , Tuberculose , Humanos , Brasil/epidemiologia , Estudos Transversais , Seguimentos , Tuberculose/tratamento farmacológico , Tuberculose/epidemiologiaRESUMO
OBJECTIVE: The national vaccination coverage survey on full vaccination at 12 and 24 months of age was carried out to investigate drops in coverage as of 2016. METHODS: A sample of 37,836 live births from the 2017 or 2018 cohorts living in capital cities, the Federal District, and 12 inner cities with 100 thousand inhabitants were followed for the first 24 months through vaccine record cards. Census tracts stratified according to socioeconomic levels had the same number of children included in each stratum. Coverage for each vaccine, full vaccination at 12 and 24 months and number of doses administered, valid and timely, were calculated. Family, maternal and child factors associated with coverage were surveyed. The reasons for not vaccinating analyzed were: medical contraindications, access difficulties, problems with the program, and vaccine hesitancy. RESULTS: Preliminary results showed that less than 1% of children were not vaccinated, full coverage was less than 75% at all capitals and the Federal District, vaccines requiring more than one dose progressively lost coverage, and there were inequalities among socioeconomic strata, favorable to the highest level in some cities and to the lowest in others. CONCLUSION: There was an actual reduction in full vaccination in all capitals and the Federal District for children born in 2017 and 2018, showing a deteriorating implementation of the National Immunization Program from 2017 to 2019. The survey did not measure the impacts of the COVID-19 pandemic, which may have further reduced vaccination coverage.
Assuntos
COVID-19 , Cobertura Vacinal , Vacinas , Criança , Humanos , Lactente , Brasil , Pandemias , VacinaçãoRESUMO
OBJECTIVE: To evaluate the impact of catastrophic costs on unfavorable tuberculosis treatment outcomes. METHODS: This was a prospective cohort study, conducted in five Brazilian state capitals (Manaus, Recife, Vitória, Campo Grande and Porto Alegre) from June 2016 to July 2018. Logistic regression was used to calculate the odds ratio (OR) and 95% confidence intervals (95%CI). RESULTS: Of the 350 participants, 310 were included, of whom 30 presented unfavorable outcomes. Catastrophic cost (OR=2.53 -95% CI 1.13;5.67) and divorce (OR=5.29 -95% CI 1.39;20.05) increased the chances of unfavorable outcomes. CONCLUSION: Financial difficulties during tuberculosis treatment may impair its outcome. Catastrophic cost and divorce were determining factors for treatment outcomes.
Assuntos
Tuberculose , Brasil , Humanos , Estudos Prospectivos , Resultado do Tratamento , Tuberculose/diagnóstico , Tuberculose/epidemiologia , Tuberculose/terapiaRESUMO
RATIONALE: A sudden onset of anosmia has been recently recognized as a symptom of coronavirus disease (COVID-19). PATIENT CONCERNS: Here, we describe a case of complete anosmia in a young male with COVID-19. Although he had fever and odynophagia, no abnormalities were observed in his nasopharyngeal mucosa, suggesting that his anosmia resulted from olfactory neuropathy. DIAGNOSES: COVID-19 was confirmed by RNA detection in nasopharyngeal swab specimen. INTERVENTIONS: The patient received olfactory training and B complex vitamins. OUTCOMES: On day 30, the patient reported complete recovery of his sense of smell. LESSONS: As early diagnosis is fundamental to control the spread of COVID-19 infection, we emphasize that anosmia identified in febrile cases during the COVID-19 epidemic may be a symptom indicative of the disease. Moreover, COVID-19-related anosmia can be completely reversible.
Assuntos
Betacoronavirus , Infecções por Coronavirus/complicações , Transtornos do Olfato/virologia , Pneumonia Viral/complicações , Adulto , COVID-19 , Infecções por Coronavirus/virologia , Humanos , Masculino , Pandemias , Pneumonia Viral/virologia , SARS-CoV-2RESUMO
INTRODUCTION: Paradoxical reaction in tuberculosis (TB) is defined as the reappearance of general symptoms, aggravation of pre-existing diseases, or appearance of new lesions despite adequate anti-TB therapy. It may result from the hyperactivity of the immune response, resulting in an intense inflammation. There are few cases of vertebral TB reported as paradoxical reaction, mainly among immunocompetents patients. PATIENT CONCERNS: We describe a male immunocompetent patient with confirmed pulmonary and meningeal TB. He was readmitted after 60 days of adequate treatment, with vertebral TB and paravertebral abscess, despite clinical improvement of the other locations. We defined as an uncommon case of a paradoxical reaction, confirmed by nuclear magnetic resonance and molecular rapid test for TB. DIAGNOSIS: Mycobacterium tuberculosis (MTB) was detected in cerebrospinal fluid by molecular rapid test (Gene Xpert MTB/ rifampicina method). Sputum research and culture were positive for the same agent. Lumbosacral spine nuclear magnetic resonance revealed bone destruction from T8 to T11, and a paravertebral collection was found. Gene Xpert MTB/rifampicina and culture were positive for M tuberculosis in the drained material of the paravertebral abscess. INTERVENTIONS: The paravertebral abscess was drainage by tomography-guided. Treatment with 4 anti-TB drugs was extended for 60 days and 2 anti-TB drugs was maintained for 10 months. There was a complete clinical improvement. OUTCOME: After draining the paravertebral abscess, the patient progressively improved and was discharged for outpatient follow-up. He was on antituberculous drugs for 1 year; subsequently, complete resolution of the infection was reported. CONCLUSION: Paradoxical reaction may be a difficult diagnosis in immunocompetent patient. Vertebral TB as a paradoxical reaction is an uncommon presentation. Therapeutic failure or resistance to treatment should be ruled out to confirm the diagnosis of paradoxical reaction.
Assuntos
Antituberculosos/efeitos adversos , Imunocompetência/efeitos dos fármacos , Tuberculose Meníngea/tratamento farmacológico , Tuberculose Pulmonar/tratamento farmacológico , Tuberculose da Coluna Vertebral/etiologia , Adulto , Antituberculosos/administração & dosagem , Antituberculosos/uso terapêutico , Humanos , Imageamento por Ressonância Magnética , Masculino , Mycobacterium tuberculosis/isolamento & purificação , Sacro/diagnóstico por imagem , Sacro/patologia , Tuberculose Meníngea/complicações , Tuberculose Pulmonar/classificação , Tuberculose da Coluna Vertebral/líquido cefalorraquidianoRESUMO
OBJECTIVE: To evaluate the treatment compliance of patients with paracoccidioidomycosis. METHODS: We studied 188 patients with paracoccidioidomycosis admitted to a tertiary referral hospital in the Central-West Region of Brazil from 2000 to 2010, to assess their compliance to treatment. In order to be considered compliant, patients needed to present two established criteria: (1) receive medicines from the pharmacy, and (2) achieve a self-reported utilization of at least 80% of the dispensed antifungal compounds prescribed since their previous appointment. RESULTS: Most patients were male (95.7%), had the chronic form of the disease (94.2%), and were treated with cotrimoxazole (86.2%). Only 44.6% of patients were treatment compliant. The highest loss to follow-up was observed in the first 4 months of treatment (p < 0.02). Treatment compliance was higher for patients with than for those without pulmonary involvement (OR: 2.986; 95%CI 1.351-6.599), and higher for patients with than without tuberculosis as co-morbidity (OR: 2.763; 95%CI 1.004-7.604). CONCLUSIONS: Compliance to paracoccidioidomycosis treatment was low, and the period with the highest loss to follow-up corresponds to the first four months. Pulmonary paracoccidioidal involvement or tuberculosis comorbidity predicts a higher compliance to paracoccidioidomycosis therapy.
Assuntos
Antifúngicos/uso terapêutico , Adesão à Medicação/estatística & dados numéricos , Paracoccidioidomicose/tratamento farmacológico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Brasil , Criança , Pré-Escolar , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Fatores de Tempo , Resultado do Tratamento , Adulto JovemRESUMO
RATIONALE: Melioidosis is an emerging infectious disease in Brazil and caused by Burkholderia pseudomallei, with high morbidity and mortality rates. A total of 28 melioidosis cases were reported in Brazil until 2015. The majority of melioidosis cases were reported in the Northwest region of Brazil and such cases were not previously detected in the Midwest region of Brazil. PATIENT CONCERNS: A 42-year-old man was admitted with a non-productive cough, dyspnea, myalgia, diffuse abdominal pain. Pulmonary auscultation revealed a vesicular murmur, snoring sounds, and the presence of basal crackling rales in the left hemithorax. The patient evolved with several respiratory failures and he was diagnosed as the first case of community-acquired pneumonia with sepsis caused by B pseudomallei in Mato Grosso do Sul, Midwest state of Brazil. DIAGNOSIS: The cell isolates were subjected to 16S rRNA gene sequencing to confirm the bacterial species. INTERVENTIONS: Administration of trimethoprim/sulfamethoxazole and meropenem stabilized the clinical condition of the patient. Subsequently upon discharge, the patient was also treated with trimethoprim/sulfametothoxazole for a year. OUTCOME: We reported the first case of community-acquired pneumonia with sepsis caused by B pseudomallei in Mato Grosso do Sul, Midwest state of Brazil and the patient survived. LESSONS: The emergence of melioidosis in the Midwest region is being neglected and underestimated and melioidosis must be considered of the differential diagnosis in community infections.
Assuntos
Burkholderia pseudomallei/isolamento & purificação , Empiema Pleural/microbiologia , Melioidose/diagnóstico , Pneumonia/microbiologia , Sepse/microbiologia , Adulto , Infecções Comunitárias Adquiridas/diagnóstico , Infecções Comunitárias Adquiridas/microbiologia , Humanos , Masculino , Melioidose/complicaçõesRESUMO
ABSTRACT Objective: To evaluate the implications of the proportion of annual family income spent in the pre- and post-diagnosis periods in tuberculosis patients followed for after at least one year after completing tuberculosis treatment in Brazil. Methods: This was a cross-sectional study of tuberculosis patients followed for at least one year after completing tuberculosis treatment in five Brazilian capitals (one in each region of the country). Results: A total of 62 patients were included in the analysis. The overall average cost of tuberculosis was 283.84 Brazilian reals (R$) in the pre-diagnosis period and R$4,161.86 in the post-diagnosis period. After the costs of tuberculosis disease, 71% of the patients became unemployed, with an overall increase in unemployment; in addition, the number of patients living in nonpoverty decreased by 5%, the number of patients living in poverty increased by 6%, and the number of patients living in extreme poverty increased by 5%. The largest proportion of annual household income to cover the total costs of tuberculosis was for the extremely poor (i.e., 40.37% vs. 11.43% for the less poor). Conclusions: Policies to mitigate catastrophic costs should include interventions planned by the health care system and social protection measures for tuberculosis patients with lower incomes in order to eliminate the global tuberculosis epidemic by 2035-a WHO goal in line with the United Nations Sustainable Development Goals.
RESUMO Objetivo: Avaliar as implicações da proporção da renda familiar anual gasta nos períodos pré e pós-diagnóstico em pacientes com tuberculose acompanhados durante pelo menos um ano após o término do tratamento da tuberculose no Brasil. Métodos: Estudo transversal com pacientes com tuberculose acompanhados durante pelo menos um ano após o término do tratamento da tuberculose em cinco capitais brasileiras (uma em cada região do país). Resultados: Foram incluídos na análise 62 pacientes. O custo médio global da tuberculose foi de R$ 283,84 no período pré-diagnóstico e de R$ 4.161,86 no período pós-diagnóstico. Após os custos da doença tuberculosa, 71% dos pacientes ficaram desempregados, com um aumento global do desemprego; além disso, o número de pacientes não pobres diminuiu 5%, o número de pacientes pobres aumentou 6% e o número de pacientes extremamente pobres aumentou 5%. A maior proporção de renda familiar anual para cobrir os custos totais da tuberculose foi observada nos pacientes extremamente pobres (40,37% vs. 11,43% nos menos pobres). Conclusões: As políticas para mitigar os custos catastróficos devem incluir intervenções planejadas pelo sistema de saúde e medidas de proteção social para pacientes de baixa renda com tuberculose, a fim de eliminar a epidemia global de tuberculose até 2035, uma meta da OMS alinhada com os Objetivos de Desenvolvimento Sustentável propostos pela Organização das Nações Unidas.
RESUMO
Resumo A fim de identificar e discutir opções informadas por evidências para abordar a judicialização da saúde no Brasil, utilizou-se as Ferramentas SUPPORT (Supporting Policy Relevant Reviews and Trials). A busca foi realizada nas bases PubMed; Health Systems Evidence; Campbell Collaboration; Cochrane Library; Rx for Change Database e PDQ-Evidence. A seleção e avaliação da qualidade metodológica foi feita por dois revisores independentes. Os resultados foram apresentados numa síntese narrativa. Dezenove revisões sistemáticas apontam quatro opções: 1) Serviço de respostas rápidas; 2) Programa de educação permanente; 3) Serviço de mediação entre as partes envolvidas; e 4) Adoção de ferramenta online (baseada em computador) de suporte à decisão e de intervenções mediadas por pacientes. Conclusões: Apresentamos e caracterizamos quatro opções que podem ser consideradas para abordar a judicialização da saúde. A implementação dessas opções deve garantir a participação de diferentes atores, refletindo sobre variados contextos. Recursos humanos e financeiros, capacitação das equipes, são os principais pontos críticos.
Abstract This article seeks to identify and discuss evidence-informed options to address the judicialization of health. The Supporting Policy Relevant Reviews and Trials Tools were used to define the problem and the search strategy, which was carried out in the following databases: PubMed, Health Systems Evidence, Campbell, Cochrane Collaboration, Rx for Change Database, and PDQ-Evidence. Selection and assessment of methodological quality was performed by two independent reviewers. The results were presented in a narrative synthesis. This study selected 19 systematic reviews that pointed out four strategies to address the judicialization of health in Brazil: 1) Rapid response service, 2) Continuous education program, 3) Mediation service between the parties involved, and 4) Adoption of a computer-based, online decision-making support tool and patient-mediated interventions. This study therefore presented and characterized four options that can be considered to address the judicialization of health. The implementation of these options must ensure the participation of different actors, reflecting on different contexts and the impact on the health system. The availability of human and financial resources and the training of teams are critical points for the successful implementation of the options.
RESUMO
OBJECTIVE:: To evaluate the frequency of and factors associated with indeterminate interferon-gamma release assay (IGRA) results in people living with HIV/AIDS (PLWHA). METHODS:: We tested 81 PLWHA in the central-west region of Brazil, using the tuberculin skin test and an IGRA. Information on sociodemographic and clinical variables was gathered through the use of questionnaires and from medical records. The association of those variables with indeterminate results was analyzed by calculating the adjusted ORs in a multivariate logistic regression model. Concordance was evaluated by determining the kappa statistic. RESULTS:: Among the 81 patients evaluated, the tuberculin skin test results were positive in 18 (22.2%) of the patients, and the IGRA results were positive in 10 (12.3%), with a kappa of 0.62. The IGRA results were indeterminate in 22 (27.1%) of the patients (95% CI: 17.8-38.1%). The odds of obtaining indeterminate results were significantly higher in smokers (adjusted OR = 6.0; 95% CI: 1.4-26.7) and in samples stored for less than 35 days (adjusted OR = 14.0; 95% CI: 3.1-64.2). Patients with advanced immunosuppression (CD4+ T-cell count < 200 cells/mm3) were at a higher risk for indeterminate results (OR adjusted for smoking and inadequate duration of sample storage = 4.7; 95% CI: 0.91-24.0), although the difference was not significant. CONCLUSIONS:: The high prevalence of indeterminate results can be a major limitation for the routine use of IGRAs in PLWHA. The need to repeat the test increases its costs and should be taken into account in cost-effectiveness studies. The processing of samples can significantly alter the results. OBJETIVO:: Avaliar a frequência de resultados indeterminados de um interferon-gamma release assay (IGRA, ensaio de liberação de interferon-gama) e os fatores relacionados com esses resultados em pessoas vivendo com HIV/AIDS (PVHA). MÉTODOS:: Foram avaliadas 81 PVHA na região Centro-Oeste do Brasil, por meio do teste tuberculínico e de um IGRA. Informações a respeito de variáveis sociodemográficas e clínicas foram obtidas por meio de questionários e prontuários médicos. A relação entre essas variáveis e os resultados indeterminados foi avaliada por meio do cálculo da OR ajustada em um modelo de regressão logística multivariada. A concordância foi avaliada por meio do coeficiente kappa. RESULTADOS:: Os resultados do teste tuberculínico e do IGRA foram positivos em 18 (22,2%) e 10 (12,3%), respectivamente, dos 81 pacientes avaliados (κ = 0,62). O resultado do IGRA foi indeterminado em 22 (27,1%) dos pacientes (IC95%: 17,8-38,1%). A chance de resultados indeterminados foi significativamente maior em fumantes (OR ajustada = 6,0; IC95%: 1,4-26,7) e em amostras armazenadas durante menos de 35 dias (OR ajustada = 14,0; IC95%: 3,1-64,2). Pacientes com imunossupressão avançada (contagem de células T CD4+ < 200 células/mm3) apresentaram maior risco de resultados indeterminados (OR ajustada para tabagismo e tempo inadequado de armazenamento das amostras = 4,7; IC95%: 0,91-24,0), embora a diferença não tenha sido significativa. CONCLUSÕES:: A alta prevalência de resultados indeterminados pode ser um grande obstáculo ao uso rotineiro de IGRAs em PVHA. A necessidade de repetir o teste aumenta seu custo e deve ser levada em conta em estudos da relação entre custo e eficácia. O processamento das amostras pode alterar significativamente os resultados.
Assuntos
Infecções Oportunistas Relacionadas com a AIDS/diagnóstico , Testes de Liberação de Interferon-gama/métodos , Tuberculose Latente/diagnóstico , Tuberculose Latente/virologia , Síndrome da Imunodeficiência Adquirida/microbiologia , Adulto , Brasil , Contagem de Linfócito CD4 , Estudos Transversais , Estudos de Viabilidade , Feminino , Humanos , Período de Incubação de Doenças Infecciosas , Testes de Liberação de Interferon-gama/economia , Masculino , Pessoa de Meia-Idade , Reprodutibilidade dos Testes , Inquéritos e Questionários , Teste Tuberculínico/métodosRESUMO
Peripheral facial paralysis (PFP) has been shown to be a neurological manifestation of COVID-19. The current study presents two cases of PFP after COVID-19, along with a rapid review of known cases in the literature. Both case reports were conducted following CARE guidelines. We also performed a systematic review of PFP cases temporally related to COVID-19 using PubMed, Embase, and Cochrane Library databases on August 30, 2021, using a rapid review methodology. The two patients experienced PFP 102 and 110 days after COVID-19 symptom onset. SARS-CoV-2 RNA was detected in nasal samples through reverse-transcription real-time polymerase chain reaction (RT-qPCR) testing. Anosmia was the only other neurological manifestation. PFP was treated with steroids in both cases, with complete subsequent recovery. In the rapid review, we identified 764 articles and included 43 studies. From those, 128 patients with PFP were analyzed, of whom 42.1% (54/128) were male, 39.06% (50/128) female, and in 23 cases the gender was not reported. The age range was 18 to 59 (54.68%). The median time between COVID-19 and PFP was three days (ranging from the first symptom of COVID-19 to 40 days after the acute phase of infection). Late PFP associated with COVID-19 presents mild symptoms and improves with time, with no identified predictors. Late PFP should be added to the spectrum of neurological manifestations associated with the long-term effects of SARS-CoV-2 infection as a post COVID-19 condition.
Assuntos
Humanos , Paralisia Facial/etiologia , COVID-19/complicações , Doenças Neuromusculares/etiologiaRESUMO
Objetivo: Avaliar o impacto dos custos catastróficos no desfecho desfavorável do tratamento da tuberculose. Métodos: Estudo de coorte prospectiva, realizado em cinco capitais de estados brasileiros (Manaus, Recife, Vitória, Campo Grande e Porto Alegre) no período de junho de 2016 a julho de 2018. Empregou-se regressão logística para calcular a razão de chances (odds ratio, OR) e os intervalos de confiança de 95% (IC95%). Resultados: Dos 350 participantes, 310 foram incluídos, dos quais 30 apresentaram desfecho desfavorável. Custo catastrófico (OR=2,53 - IC95% 1,13;5,67) e divórcio (OR=5,29 - IC95% 1,39;20,05) aumentaram as chances de desfecho desfavorável. Conclusão: Dificuldades financeiras durante o tratamento da tuberculose podem prejudicar seu desfecho. Os fatores determinantes para o desfecho do tratamento foram custo catastrófico e divórcio.
Objetivo: Evaluar el impacto de los costos catastróficos en el resultado desfavorable del tratamiento de la tuberculosis. Métodos: Estudio de cohorte prospectiva realizado en cinco capitales de estados brasileños (Manaus, Recife, Vitória, Campo Grande y Porto Alegre) entre junio de 2016 y julio de 2018. Se utilizó la regresión logística para calcular los odds ratios (OR) y los intervalos de confianza del 95% (IC95%). Resultados: De los 350 participantes, se incluyeron 310, y 30 tuvieron resultado desfavorable. El costo catastrófico (OR=2,53 - IC95% 1,13;5,67) y el divorcio (OR=5,29 - IC95% 1,39;20,05) aumentaron la obtención de un resultado desfavorable. Conclusión: Dificultades económicas enfrentadas durante el tratamiento de la tuberculosis pueden perjudicar el resultado del tratamiento. Las determinantes del tratamiento fueron el costo catastrófico y el divorcio.
Objective: To evaluate the impact of catastrophic costs on unfavorable tuberculosis treatment outcomes. Methods: This was a prospective cohort study, conducted in five Brazilian state capitals (Manaus, Recife, Vitória, Campo Grande and Porto Alegre) from June 2016 to July 2018. Logistic regression was used to calculate the odds ratio (OR) and 95% confidence intervals (95%CI). Results: Of the 350 participants, 310 were included, of whom 30 presented unfavorable outcomes. Catastrophic cost (OR=2.53 -95% CI 1.13;5.67) and divorce (OR=5.29 -95% CI 1.39;20.05) increased the chances of unfavorable outcomes. Conclusion: Financial difficulties during tuberculosis treatment may impair its outcome. Catastrophic cost and divorce were determining factors for treatment outcomes.
Assuntos
Humanos , Tuberculose/diagnóstico , Tuberculose/terapia , Resultado do Tratamento , Custos e Análise de Custo , Fatores Socioeconômicos , Tuberculose/epidemiologia , Brasil/epidemiologia , Estudos ProspectivosRESUMO
Avaliar capacidades, arranjos organizativos e barreiras à implementação dos Núcleos de Evidências (NEvs) da Rede de Políticas Informadas por Evidências (EVIPNet) no Brasil. Realizou-se um estudo exploratório de casos múltiplos, descritivo-analítico, com abordagem mista. Os coordenadores dos NEvs em atividade no país responderam um instrumento com três partes: caracterização do respondente, avaliação da capacidade de "adquirir, avaliar, adaptar e aplicar" evidências (4A) e questões abertas abordando arranjos organizativos e barreiras à implementação dos NEvs. Participaram da pesquisa 15 NEvs, concentrados no Centro-Oeste; 73,3% estavam sediados em universidades e 20% em secretarias estaduais/municipais ou no Ministério da Saúde. Dos coordenadores participantes, 100% possuíam pós-graduação lato e/ou strictu sensu e 80% referiram experiência de 1 a 5 anos em políticas informadas por evidências (PIE) e proficiência em inglês. Nenhum coordenador atuava exclusivamente no NEv. As equipes incluíam profissionais de saúde, estudantes (graduação/pós-graduação), docentes de universidades e servidores efetivos em secretarias de saúde. Foram identificadas alta capacidade para "adquirir" e "avaliar" e baixa capacidade para "adaptar" e "aplicar" evidências. Quanto a atividades e produtos, prevaleceu a média de três por ano, com destaque para produtos de tradução do conhecimento (sínteses de evidência e diálogos deliberativos) e capacitação para profissionais de saúde, gestores e alunos de graduação/pós-graduação. Cinco categorias de barreiras foram descritas: 1) financiamento, 2) integração da rede, 3) institucionalização das demandas, 4) capacidade de adaptação e 5) habilidades de comunicação de pesquisa para recomendar ações no nível local. Existem recursos humanos capacitados, vinculados a instituições de pesquisa e ensino, para apoiar as PIE. No entanto, a sustentabilidade dos NEvs depende de ações coordenadas para garantir a capacidade de adaptar e aplicar evidências.
Evaluar la capacidad, los arreglos organizativos y los obstáculos existentes para la aplicación de los núcleos de evidencia (NEv) de la Red de Políticas Informadas por Evidencia (EVIPNet) en Brasil. Se realizó un estudio descriptivo, analítico y exploratorio de casos múltiples, con un enfoque mixto. Los coordinadores de los NEv activos en el país respondieron a un instrumento dividido en tres partes: caracterización de la persona encuestada, evaluación de la capacidad de "adquirir, evaluar, adaptar y aplicar" evidencia (conocidas como 4A por su sigla en portugués) y temas de discusión abierta en los cuales se abordaron los arreglos organizativos y los obstáculos existentes para la aplicación de los NEv. Participaron en la investigación 5 NEv concentrados en la región Centro-Oeste; 73,3% tenían su sede en universidades y un 20% en secretarías estatales/municipales o en el Ministerio de Salud. Todos los coordinadores participantes tenían título de posgrado en sentido amplio o estricto y 80% afirmaron que tenían experiencia de 1 a 5 años en políticas informadas por evidencia (PIE) y que dominaban el inglés. Ningún coordinador trabajaba exclusivamente en el NEv. Los equipos incluían profesionales de salud, estudiantes (de grado/posgrado), profesores universitarios y empleados en comisión de servicio en las secretarías de salud. Se determinó que tenían gran capacidad para "adquirir" y "evaluar" y poca capacidad para "adaptar" y "aplicar" evidencias. En cuanto a actividades y productos, prevaleció la media de tres al año, con hincapié en los productos de traducción del conocimiento (la síntesis de la evidencia y los diálogos deliberantes) y la capacitación para profesionales de salud, gestores y alumnos de grado/posgrado. Se describieron cinco clases de obstáculos: 1) financiamiento, 2) integración de la red, 3) institucionalización de las demandas, 4) capacidad de adaptación y 5) habilidades de comunicación de las investigaciones para recomendar la adopción de medidas en el nivel local. Existen recursos humanos capacitados, vinculados a instituciones de investigación y enseñanza, para apoyar las PIE. Sin embargo, la sostenibilidad de los NEv depende de la adopción de medidas coordinadas para garantizar que existe la capacidad de adaptar y aplicar evidencia
To evaluate capacities, organizational arrangements, and barriers to the implementation of Evidence Centers (NEvs) as part of Brazil's Evidence-Informed Policy Network (EVIPNet). A mixed methods descriptive-analytical, multiple-case exploratory study was performed. Coordinators of active NEvs answered a questionnaire in three parts: participant characteristics, assessment of the capacity to "acquire, assess, adapt, and apply" evidence (4A), and open questions addressing organizational arrangements and barriers to the implementation of NEvs.The study included 15 NEvs, mostly from the Midwest; 73.3% were based in universities, while 20% were installed in state/city health departments or in the Ministry of Health. All coordinators had completed graduate training and 80% reported 1 to 5 years' experience with evidence-based policies as well as proficiency in English. None of the participants worked exclusively as NEv coordinator. NEv teams included health care professionals, students (undergraduate/graduate), professors, and civil servants from health departments. The data revealed high capacity to "acquire" and "assess" evidence, and low capacity to "adapt" and "apply" evidence. On average, three activities or products were developed yearly by each NEv, especially knowledge translation initiatives (systematic reviews and deliberative dialogues) and training for health care professionals, managers and undergraduate/graduate students. Five barrier categories were described: 1) financing, 2) network integration, 3) institutionalization of demands, 4) adaptive capacity, and 5) research communication skills to recommend actions at the local level. Trained human resources associated with academic and research institutions are available to support evidence-informed policies. However, the sustainability of NEvs depends on coordinated action to ensure the capacity to adapt and apply evidence.
Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Formulação de Políticas , Política Informada por Evidências , Ciência Translacional Biomédica , BrasilRESUMO
With the objective to evaluate the behavior of paracoccidioidomycosis in the last three decades, clinical and epidemiological data of 595 patients admitted to clinical services of the Federal University of Mato Grosso do Sul from 1980 to 2009 were investigated. Gender, age distribution, clinical form, comorbidity with tuberculosis or AIDS, and mortality were compared by decades of clinical admission. It was shown that during the three decades there was a decrease in women percentage, and the same manner occurred a reduction in participants in the age group of 20 to 39 years. Moreover, the acute/subacute forms have been diminished in the period. These fluctuations are closely related and can be simultaneously analyzed. Increased AIDS co-infection prevalence from the first to the second decade was also revealed, coinciding with the appearance of the retroviral epidemic and stabilizing during the third decade. No change in the tuberculosis co-infection rate was observed (overall = 6.9%). It reinforces the importance of this co-morbidity. The overall mortality rate remained steady at 6.7%, not varying significantly from one decade to another. The persistent mortality rate calls attention to the importance of this neglected disease.
Assuntos
Paracoccidioidomicose/epidemiologia , Doença Aguda , Adolescente , Adulto , Distribuição por Idade , Brasil/epidemiologia , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , Prevalência , Distribuição por Sexo , Adulto JovemRESUMO
ABSTRACT Objective: To evaluate the treatment compliance of patients with paracoccidioidomycosis. Methods: We studied 188 patients with paracoccidioidomycosis admitted to a tertiary referral hospital in the Central-West Region of Brazil from 2000 to 2010, to assess their compliance to treatment. In order to be considered compliant, patients needed to present two established criteria: (1) receive medicines from the pharmacy, and (2) achieve a self-reported utilization of at least 80% of the dispensed antifungal compounds prescribed since their previous appointment. Results: Most patients were male (95.7%), had the chronic form of the disease (94.2%), and were treated with cotrimoxazole (86.2%). Only 44.6% of patients were treatment compliant. The highest loss to follow-up was observed in the first 4 months of treatment (p < 0.02). Treatment compliance was higher for patients with than for those without pulmonary involvement (OR: 2.986; 95%CI 1.351-6.599), and higher for patients with than without tuberculosis as co-morbidity (OR: 2.763; 95%CI 1.004-7.604). Conclusions: Compliance to paracoccidioidomycosis treatment was low, and the period with the highest loss to follow-up corresponds to the first four months. Pulmonary paracoccidioidal involvement or tuberculosis comorbidity predicts a higher compliance to paracoccidioidomycosis therapy.
RESUMO Objetivo: Avaliar a adesão ao tratamento de paracoccidioidomicose. Métodos: Estudo conduzido com 188 pacientes com paracoccidioidomicose atendidos em um hospital terciário na Região Centro-Oeste do Brasil, de 2000 a 2010, para avaliar adesão ao tratamento. Foram considerados aderentes pacientes que tiveram o seguinte critério: retiraram os medicamentos na farmácia e autorrelataram a utilização de, no mínimo, 80% de dispensação dos antifúngicos prescritos na última consulta. Resultados: A maioria dos pacientes era homem (95,7%), tinha a forma crônica da doença (94,2%) e foi tratada com sulfametoxazol/trimetropim (86,2%). Apenas 44,6% dos pacientes aderiram ao tratamento. A maior perda de seguimento foi observada nos primeiros 4 meses de tratamento (p < 0,02). Adesão ao tratamento foi maior em pacientes com do que sem envolvimento pulmonar (RC: 2,986; IC95% 1,351-6,6599) e maior para os pacientes com do que sem tuberculose associada (RC 2,763; IC95% 1,004-7,604). Conclusões: A adesão ao tratamento da paracoccidioidomicose foi baixa e os primeiros 4 meses constituíram o período com maior evasão. Pacientes com envolvimento paracocidióidico pulmonar ou tuberculose associada revelaram maior adesão ao tratamento da paracoccidioidomicose.
Assuntos
Humanos , Masculino , Feminino , Pré-Escolar , Criança , Adolescente , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Adulto Jovem , Paracoccidioidomicose/tratamento farmacológico , Adesão à Medicação/estatística & dados numéricos , Antifúngicos/uso terapêutico , Fatores de Tempo , Brasil , Estudos Prospectivos , Seguimentos , Resultado do TratamentoRESUMO
INTRODUCTION: Jailed populations exhibit high rates of tuberculosis (TB) infection and active disease. METHODS: A cross-sectional study was performed to estimate the prevalence of latent and active TB and to identify factors associated with latent infection in inmates. RESULTS: The prevalence of latent TB was 49%, and the prevalence of active TB was 0.4%. The presence of a Bacille Calmette-Guérin (BCG) scar (prevalence ratio (PR)=1.65; 95% confidence interval (CI): 1.09-2.50; p=0.0162) and the World Health Organization (WHO) score for active TB in prisons (PR=1.07; 95% CI: 1.01-1.14; p=0.0181) were correlated with infection. CONCLUSIONS: The identification of associated factors and the prevalence of latent and active TB allows the development of plans to control this disease in jails.
Assuntos
Tuberculose Latente/epidemiologia , Mycobacterium tuberculosis/isolamento & purificação , Prisioneiros/estatística & dados numéricos , Tuberculose Pulmonar/epidemiologia , Adolescente , Adulto , Brasil/epidemiologia , Estudos Transversais , Humanos , Tuberculose Latente/diagnóstico , Masculino , Prevalência , Fatores de Risco , Teste Tuberculínico , Tuberculose Pulmonar/diagnóstico , Adulto JovemRESUMO
Objective: To identify the qualification of and to know the work of Family Health Strategy nurses in oncology care. Methods: A cross-sectional, descriptive study, using a quantitative approach, was conducted with 77 nurses working in the Family Health Strategy units of Campo Grande, state of Mato Grosso do Sul. Primary data were collected in structured interviews, using a form with closed-ended questions. Results: Professional training in oncology care is less frequent, reflecting a high lack of knowledge regarding the National Policy on Oncology Care. It was evidenced that 95% of the professionals assisted oncology patients, with home visits and nursing appointments being the most prevalent methods. Regarding the National Policy on Oncology Care, 96% of the nurses declared that they did not know about it. Conclusion: There was evidence of weakness in the care provided by the nurses to oncology patients and the need for investment in continuing education for professional nurses regarding oncology care.
Objetivo: Identificar la calificación y conocer la actuación de los enfermeros de la Estrategia Salud de la Familia en atención oncológica. Métodos: Estudio transversal, de abordaje cuantitativo, integrado por 77 enfermeros actuantes en unidades de Estrategia Salud de la Familia de Campo Grande, Mato Grosso do Sul. Datos primarios recolectados mediante entrevista, utilizándose cuestionario con preguntas cerradas. Resultados: La capacitación en atención oncológica es poco frecuente, reflejando el elevado desconocimiento de la Política Nacional de Atención Oncológica. Se verificó que 95% de los profesionales realizaban atenciones a pacientes oncológicos, prevaleciendo la visita domiciliaria y la consulta de enfermería. Sobre la Política Nacional de Atención Oncológica, 96% de los enfermeros declaró desconocerla. Conclusión: Se evidenció falta de preparación de los enfermeros para atender a pacientes con cáncer, y la necesidad explícita de educación continua.
Objetivo: Identificar a qualificação e conhecer a atuação dos enfermeiros da Estratégia Saúde da Família na atenção oncológica. Métodos: Estudo transversal de abordagem quantitativa, constituído de 77 enfermeiros inseridos em unidades de Estratégia Saúde da Família de Campo Grande, Mato Grosso do Sul. A coleta de dados primários foi realizada por meio de entrevista, utilizando-se um formulário com questões fechadas. Resultados: A capacitação, em atenção oncológica, é pouco frequente, refletindo o elevado desconhecimento da Política Nacional de Atenção Oncológica. Verificou-se que 95% dos profissionais realizavam atendimentos aos pacientes oncológicos, sendo a visita domiciliar e a consulta de enfermagem as mais prevalentes. Sobre a Política Nacional de Atenção Oncológica, 96% dos enfermeiros declararam não a conhecer. Conclusão: Evidenciou-se despreparo dos enfermeiros para assistirem os pacientes portadores de câncer e a necessidade explícita de educação permanente.
Assuntos
Humanos , Adulto , Estratégias de Saúde Nacionais , Enfermagem Oncológica , Atenção Primária à SaúdeRESUMO
ABSTRACT Objective: To evaluate the frequency of and factors associated with indeterminate interferon-gamma release assay (IGRA) results in people living with HIV/AIDS (PLWHA). Methods: We tested 81 PLWHA in the central-west region of Brazil, using the tuberculin skin test and an IGRA. Information on sociodemographic and clinical variables was gathered through the use of questionnaires and from medical records. The association of those variables with indeterminate results was analyzed by calculating the adjusted ORs in a multivariate logistic regression model. Concordance was evaluated by determining the kappa statistic. Results: Among the 81 patients evaluated, the tuberculin skin test results were positive in 18 (22.2%) of the patients, and the IGRA results were positive in 10 (12.3%), with a kappa of 0.62. The IGRA results were indeterminate in 22 (27.1%) of the patients (95% CI: 17.8-38.1%). The odds of obtaining indeterminate results were significantly higher in smokers (adjusted OR = 6.0; 95% CI: 1.4-26.7) and in samples stored for less than 35 days (adjusted OR = 14.0; 95% CI: 3.1-64.2). Patients with advanced immunosuppression (CD4+ T-cell count < 200 cells/mm3) were at a higher risk for indeterminate results (OR adjusted for smoking and inadequate duration of sample storage = 4.7; 95% CI: 0.91-24.0), although the difference was not significant. Conclusions: The high prevalence of indeterminate results can be a major limitation for the routine use of IGRAs in PLWHA. The need to repeat the test increases its costs and should be taken into account in cost-effectiveness studies. The processing of samples can significantly alter the results.
RESUMO Objetivo: Avaliar a frequência de resultados indeterminados de um interferon-gamma release assay (IGRA, ensaio de liberação de interferon-gama) e os fatores relacionados com esses resultados em pessoas vivendo com HIV/AIDS (PVHA). Métodos: Foram avaliadas 81 PVHA na região Centro-Oeste do Brasil, por meio do teste tuberculínico e de um IGRA. Informações a respeito de variáveis sociodemográficas e clínicas foram obtidas por meio de questionários e prontuários médicos. A relação entre essas variáveis e os resultados indeterminados foi avaliada por meio do cálculo da OR ajustada em um modelo de regressão logística multivariada. A concordância foi avaliada por meio do coeficiente kappa. Resultados: Os resultados do teste tuberculínico e do IGRA foram positivos em 18 (22,2%) e 10 (12,3%), respectivamente, dos 81 pacientes avaliados (κ = 0,62). O resultado do IGRA foi indeterminado em 22 (27,1%) dos pacientes (IC95%: 17,8-38,1%). A chance de resultados indeterminados foi significativamente maior em fumantes (OR ajustada = 6,0; IC95%: 1,4-26,7) e em amostras armazenadas durante menos de 35 dias (OR ajustada = 14,0; IC95%: 3,1-64,2). Pacientes com imunossupressão avançada (contagem de células T CD4+ < 200 células/mm3) apresentaram maior risco de resultados indeterminados (OR ajustada para tabagismo e tempo inadequado de armazenamento das amostras = 4,7; IC95%: 0,91-24,0), embora a diferença não tenha sido significativa. Conclusões: A alta prevalência de resultados indeterminados pode ser um grande obstáculo ao uso rotineiro de IGRAs em PVHA. A necessidade de repetir o teste aumenta seu custo e deve ser levada em conta em estudos da relação entre custo e eficácia. O processamento das amostras pode alterar significativamente os resultados.